Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

SPRING16 757 PC Adults > Male GU > Flashcards

Male GU Flashcards

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

1
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

Male GU Lateral View - anatomy

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

anatomy of the prostate

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

FUNCTION OF THE PROSTATE GLAND

A
  • Exocrine gland
  • Store and secrete basic fluid that constitutes 1/3 of semen
  • Secretion of proteolytic enzymes and psa as well as zinc and citric acid
  • Keeps basic environment within the acidic vagina allowing sperm to survive
  • 20-40 gms (size of walnut) rubbery
  • Both glandular and smooth muscle allowing expulsion of semen
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

most common form of cancer in adult males in all age groups

A

prostate cancer

currently surpasses the incidence of lung cancer

second leading cause of death from cancer in men in the United States.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

association of age and likelihood of developing prostate cancer

A
  • likelihood of developing prostate cancer increases from 1 in 2,667 in ages 50 – 54 to 1 in 80 for men aged 80 – 84.
  • 85% of all prostate cancers are diagnosed in men older than 65 years (Gronberg, 2003) making this a disease of an older, vulnerable population.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

ten-year survival rate for a man diagnosed with localized prostate cancer

A

approaches 100% (in 2007)

Called an indolent dz - is clinically latent in 70% of men. More die w/dz than of it

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

What is PSA and when is it elevated?

***exam

A
  • Serine protease
  • Outstanding semen liquidfier
  • Elevated in 3 urologic conditions, not always malignancy
    • Prostate cancer
    • Infections
    • Prostate growth
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

What is PSA 3?

***exam

A
  • Gene testing
  • urine based test collected after DRE (sufficient # prostate cells to evaluate pts risk for cancer)
  • use if repeat psa remains high, suspicion for prostate cancer w/nl psa
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

PSA screening and prostate cancer: when to screen, nl values, how to interpret

***exam

A
  • Serum test
  • Guidelines recommend screening at age 40
  • Very inexpensive and routine
  • Normal values
  • Values > 4 ng/ml relates to 27% positive biopsy 2.5% high risk/
  • PSA velocity more accurate diagnosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

How have rates of prostate cancer changed since introduction of PSA screening?

A
  • From 19,000 cases/year before PSA to 200,000/year now
  • Rates now stabilized

Cooperberg, Moul and Carroll (2005) state that “A significant proportion of men with prostate cancer may be over diagnosed, in the sense that diagnosis may not improve their lifespan or quality of life. However, the extent to which over diagnosis represents a true problem relates to the consistency with which diagnosis leads invariably to active treatment” (p. 8125).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

Risk factors for prostate cancer

***exam

A
  • African American men highest
  • Family history of male relative
  • Diet related (virtually non-existent in countries with low fat diets)
  • older age (rare before 40 yo. Most commonly diagnosed in 65+ yo)
  • BRCA1 or BRCA2 mutation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

What to do with an abnormal PSA?

***exam

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

Further diagnostic tests for prostate cancer

***exam

A
  • Digital rectal exams (routine?)
  • Transurethra biopsy
  • Transrectal biopsy indications
  • False negatives
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

Prostate

Gleason scoring from biopsy results

***exam

A
  • Indicates cellular differentiation
    • 2-4 well-differentiated
    • 5-7 intermediate differentiated
    • 8-10 poorly differentiated – poorer prognosis
  • TNM system
    • T1 nonpalpable
    • T4 metastasis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

Prostate Cancer Curative Treatments

A
  • Radical Prostatectomy
  • Internal/External Beam Radiation therapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

Complications of prostate surgery

A
  • impotence:
    • rates following radical prostatectomy: 7 - 72%
    • rates following brachytherapy: 5 - 51%%
      • May be failure to report pre-existing erectile dysfunction (ED) prior to treatment
  • Incontinence, and rectal issues​
  • urinary incontinence: ~25% (Heidenreich, Ohlmann, Ozgur & Engelman, 2006).
  • Rectal discomfort following radiation: ~39% (Heidenreich et al., 2006)
  • Fecal incontinence between 8 and 56%.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

What is BPH?

A
  • Benign Prostatic Hyperplasia (BPH)
  • Refers to a histological finding
    • No inherent clinical meaning
  • Many men will have BPH but no symptoms
  • Presence of BPH increases with age
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

Is BPH the cause of LUTS?

A
  • lower urinary tract symptoms (LUTS) are commonly attributed to enlargement of the prostate.
  • BPH is a pathology that leads to enlargement= may obstruct the urethra leading to LUTS.
  • Because BPH is a histological finding, it requires a tissue sample for true diagnosis.
  • BPH is more prevalent in the more aged population, however not every patient with BPH will have LUTS. Also, not all patients with LUTS have BPH.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

Why use the term LUTS instead of BPH?

A

Removes implication that symptoms have organ specific cause

symptom based diagnosis, instead of a histological one

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

2 categories of LUTS

A
  • Voiding or obstructive symptoms
  • Storage or irritative symptoms
  • These divisions then are correlated with particular etiologies.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

What is the International prostate symptom score (IPSS)?

A

Validated subjective questionnaire for LUTS

Seven symptoms evaluated:

  • Weak flow of stream -Intermittency
  • Difficulty initiating stream -Nocturia
  • Straining to void -Frequency Urgency

Each scored 0-5

Total score 0-7 Mild; 8-19 Moderate; 20-35 Severe LUTS

Bother score: Single concluding question evaluating quality of life with LUTS (1 to 6, one being the most pleased, and 6 being the most dissatisfied) heavily weighed when determine whether or not to intervene, scored 1-6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

What is Bladder Outlet Obstruction (BOO)?

A
  • may develop from progressive BPH and worsen LUTS, especially voiding symptoms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

How to evaluate Bladder Outlet Obstruction?

A
  • Non-invasive uroflowmetry may provide some objective diagnostic data
    • Patient voids into weighed receptacle to measure volume and rate of flow
  • Post void residual
    • Measured in mls, elevated in BOO
      • Near 0 in normal voiding, but no specific cut-off for an elevated PVR
      • ultrasound or in/out catheterization
      • Bladder Scanner: ultrasonic machine dedicated to measurement of bladder volume
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

The case for active surveillance of tumors of prostate

A

In a study of 299 men characterized with indolent tumors and undergoing active surveillance, Klotz (2005) found that after eight years, the disease specific survival rate was 99% and that most men in the sample died of other causes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

For whom is active surveillance recommended?

A
  • active surveillance [AS] has been supported in men
  • Over the age of 65
  • low grade and stage disease
  • low and stable serum prostate specific antigen (PSA) levels.
  • However, AS has been associated with illness uncertainty
  • Used by about 10% of eligible patients
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

How often does PSA rise after local treatment?

A

May occur in 2/3 of patients treated with radical prostatectomy or radiation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

Health maintenance and promotion in Male GU cancer

A
  • Penile Self-exams
  • Testicular self-exams
  • men > 50 years and men with family history of prostate cancer should check prostate specific antigen (PSA) for screening for prostate cancer {PSA can be elevated with inflammation also}
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

Some common prostate problems besides prostate cancer

A
  • Benign prostate hyperplasia (BPH) enlargement of prostate secondary to change in sex hormones which causes urethral obstruction so decreased urine outflow & increased potential for urinary tract infection
    • This is very common in men > 70 years
  • Bacterial prostatitis
  • Nonbacterial prostatitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

Clinical presentation of BPH

A
  • As the gland enlarges, there is a resistance to urine flow
  • Bladder muscle hypertrophies
  • Emptying becomes incomplete
  • Increase in residual urine
  • Increase in chance of infection
  • Sometimes bladder diverticula
  • Acute urinary retention
  • Painless hematuria
  • Weak stream
  • Straining
  • Hesitancy
  • Nocturia
  • urgency
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

Significance of an AUA score

A

(IPSS)

  • Incomplete emptying
  • Frequency
  • Nocturia
  • Straining
  • Weak system
  • Hesitancy
  • Interrupted stream
  • AUA SCORE > 8 WARRANTS THERAPY for BPH/LUTS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

How to diagnose BPH/LUTS

A

•Goroll, page 918 AUA symptom index. Use this screening tool to have

patient complete self assessment

  • Obtain a urine, check for blood and or infection
  • Would need to see urologist for post void amount. May not need to do

In primary care setting, ?? Cost of specialist

•Imaging, but then again, cost?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

Medications to avoid in BPH/LUTS

watchful waiting

A
  • Diuretics
  • Anticholinergics
  • Tricyclic antidepressants
  • Watch over the counter meds
  • Avoid stimulants before bed
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

Medications for BPH

A
  • alpha-1-adrenergic antagonists to relax prostate and bladder muscle contractility - Tamsulosin (Flomax) ; terazosin (Hytrin)
  • Hypotensive effects
  • 5-alpha-reductase inhibitors to reduce size of prostate gland Finasteride (Proscar); dutasteride (Avodart)
  • Erectile dysfunction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

Differential if acute scrotal pain in

A

infection, STI, torsion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

Diagnosing torsion

A
  • Sudden pain
  • No cremasteric reflex
  • Scrotum not swollen
  • Get ultrasound
  • Surgical emergency!!
    • Have only a few hours (after 12 hrs. Patient will most likely loose testical
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

What is prostatitis?

causes

A
  • Acute prostatitis – inflammation and infection requires antibiotics
  • Gm negative, e coli, proteus, klebsiella, pseudomonas, enterococci
  • Chlamydia
  • HIV, watch for fungal: aspergillus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

Presentation of Acute Prostatitis?

A

Acute Onset

  • Fever
  • perineal pain
  • dysuria
  • decreased urine flow

Patient looks ill, be careful not to examine prostate aggressively , this could increase risk for bacteremia

38
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

Outpatient management of acute prostatitis?

A

start on oral antibiotic treatment x minimum 3-4 weeks

  • Cipro
  • Bactrim
  • Levaquin
  • Doxyclycline
  • Amoxicillin
39
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

comfort care for acute prostatitis

A
  • hot sitz baths: 2-3x/days
  • bedrest
  • tylenol
  • stool softeners
40
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

Medical MGMT of chronic prostatitis?

A
  • Difficult to treat
  • May need referral
  • Prostatic fluids become more alkaline
    • Need long term 8-12 weeks
    • Doxyclycline
    • Cipro
    • Sulfa ds
    • Alpha blocker
  • May need admission to hospital, esp if high fever and ?abscess
41
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

Supportive MGMT of chronic prostatitis

A
  • No etoh
  • Coffee
  • Tea
  • Keep bladder flat
  • No anticholinerics
  • Watch sedatives, ssri
42
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

Characteristics of penile cancer

A

squamous cell with fast metastasis due to the abundance of lymph glands, may be more potential for noncircumcised

43
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

Characteristics of testicular cancer

A

no known etiology however there is a correlation with undescended testicles and testicular cancer later in life, good PX if diagnosed early

44
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

are seminomas sensitive to radiatio and chemo?

A

yes

testicular cancer is one of most treatable /curable

45
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

  • Which of the following testicular screening is recommended for adolescent and adult males?
    • Monthly self exams
    • No screening
    • Annual pe of the testicles
    • Testicular ultrasound biannually in men with strong history
A

No screening

low incidence, high cure rate

46
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

Common myths about sexuality and age

A
  • sexual desires diminish with age
  • Sex after 40 should be illegal
  • sexual intercourse is a young, healthy person’s activity for the purpose of procreation
  • Sex in long-term care facilities is against the rules
47
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

Recommended sexuality and contraceptive use Qs

A
  • Can you tell me how you express your sexuality?
  • What concerns do you have about fulfilling your continuing sexual needs?
  • In what ways has your sexual relationship with your partner changed as you have aged?
  • What interventions or information can I provide to help you to fulfill your sexuality?
  • What questions do you have about your continuing sexual needs and function?
  • Do you use protection against pregnancy?
  • Have you had any sexual contact with a partner who may have a sexually transmitted disease?
48
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

What is the PLISSIT Model?

A
  • P obtaining permission from the client to initiate sexual discussion
  • LI providing the limited information needed to function sexually
  • SS giving specific suggestions for the individual to proceed with sexual relations
  • IT providing intensive therapy surrounding the issues of sexuality for that client
49
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

Common viral STIs + Tx

A
  • Herpes Type 1 & 2 – Acyclovir, Famciclovir, Valacyclovir (first episode, recurrence, and suppression regimines)
  • HPV – podophyllin, alvara
  • HIV – already discussed in earlier class
  • Hepatitis A, B, C, D, E (study in GI class)
50
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

Common fungal STIs + Tx

A

Candida albicans – candidiasis - Diflucan

51
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

Common protozoan STIs + Tx

A

Trichomonas vaginalis – trichomoniasis Metronidazole (flagyl) Be aware of no ETOH when taking

52
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

Common bacterial STIs + Tx

A
  • Bacterial vaginosis - metronidazole
  • Neisseria gonorrhorae – gonorrhea –Ceftriaxone, ciprofloxacin, levofloxacin
  • Treponema pallidium – syphillis - penicillin
  • Chlamydia trachomates* – chlamydia – azithromycin or doxcycline or ceftriaxone
53
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

Effect of decreased testosterone on erectile function

A
  • seems to have a limited impact on sexual functioning due to the fact that only a minimal amount of testosterone is needed for the purposes of sex.
  • The loss of testosterone is not pathological and does not result in sexual dysfunction.
  • labeled viropause, andropause and male menopause generally begins between the ages of 46 and 52
54
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

Changes in sexual fx associated with normal aging

A
  • As a result of normal aging changes older men require more direct stimulation of the penis to experience a somewhat weaker erection
  • orgasms are fewer and weaker in older men, the force
  • amount of ejaculation is reduced
  • the refractory period after ejaculation is significantly increased
  • The persistent inability to attain and maintain an erection adequate for sexual activity
  • The Massachusetts male aging study of 1085 older men indicated that age was an independent risk factor for decreased sexual function in men
55
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

Secondary sexual dysfunction

A
  • Rosen (2006) main predictors of sexual dysfunction are:
  • Age
  • cardiovascular diseases
  • Diabetes
  • depression
  • other diseases such as strokes, Parkinson’s disease (PD) and Benign Prostatic Hypertrophy (BPH) also interfere with sexual function
56
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

Medications that affect sexual functioning

A

1) antihypertensives including: ACE inhibitors, Alpha Blockers, Beta Blockers, Calcium Channel Blockers, Clonidine, Methyldopa and Thiazide Diuretics
2) antidepressants including SSRIs, Tricyclic Antidepressants, MAOIs

3) cholesterol lowering medications including statins and fibrates

4) other medications such as antipyschotics (Phenothiazines & Risperdone) seizure medications (Carbamazepine) and H2 Blockers (Cimetidine)

57
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

Strategies for promoting sexual function

A
  • planning for more time during sexual activities,
  • being sensitive to changes in one another’s bodies,
  • the use of aids to increase stimulation and lubrication,
  • the exploration of foreplay
  • Masturbation
  • sensual touch
  • different sexual positions
  • education about these common changes associated with sex and aging
58
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

Erectile Dysfunction Treatment Options

A
  • Oral Erectile agents assists with erections by increasing blood flow to penis, be aware of interaction with nitrates
  • Sildenafil Citrate (Viagra®) 100 mg: found to be well-tolerated
  • Vardenafil HCL(Levitra) 20 mg
  • Tadalafil HCL (Cialis)– 20 mg
  • Cavernosal injection therapy
  • Balloon implants
59
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

Important teaching r/t sexual dysfunction

A
  • Teach what’s down there and how to use it.
  • Introduce to resources
  • Use as an opportunity to promote health
    • Diabetes
    • smoking
60
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

Methods to compensate for normal and pathological physical changes r/t sexual dysfunction

A
  • medications
  • artificial water-based lubricants (K-Y silky)
  • alternative methods of intimacy
  • treat pathological conditions when possible
61
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

% HIV cases are over 50 years old?

A

11-15% (up from 10% five years ago)

Safe sex rules apply to older adults too

Lillian and the condoms

62
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

Who gets bicycle seat neuropathy and how does it present?

A
  • Common injury in male and female cyclists
  • Underreported
  • Long distance races
  • Perineal numbness
  • Related to saddle pressure
63
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

Patho of bicycle seat neuropathy

A
  • Compression of pudendal nerve that innervates genital and perineal regions
  • Frequently causes impotence after cycling
64
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

Testosterone and mental health

A

Low Testosterone Levels linked with higher risk for depression

Their study, which appears in the March issue of the Archives of General Psychiatry, shows that older men with abnormally low free testosterone levels, or hypogonadism, were on average 271% more likely to display clinically significant signs of depression than men with higher testosterone levels.

65
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

What is hypogonadism?

***exam

A
  • failure of the testis to produce physiological levels of testosterone and normal number of spermatozoa
66
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

Primary hypogonadism

***exam

A

decrease in testosterone and sperm production

primary cause is natural decline in rate of production starting in 3rd decade of life

67
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

Secondary hypogonadism

***exam

A

Low testosterone 2/2 insufficient stimulation of Leydig cells

Result of hypothalamic and pituitary DOs or lesions - hyperprolacinemia, Kallman syndrome

68
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

Rates of hypogonadism in >45yo

***exam

A

38.7% > 45 yrs have

69
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

Types of hypogonadism, causes

***exam

A
  • Primary and secondary, we are addressing secondary
  • Causes? Chemo, radiation, ETOH abuse, some meds
70
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

PE in setting of older male w/fatigue, decreased concentration, decreased sex drive, ED

***exam

A
  • Inspect: testes, upper and lower musculature, beard, gynecomastia
  • Palpate: scrotum and testes for masses, breasts for masses
  • Labs: free testosterone ( 8 am), avoid labs if acute illness
71
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

Hormone replacement in geriatrics, HIV

***exam

A
  • Geriatrics: not in favor of hormone treatment, benefits unproven
  • HIV, short term ok
72
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

How does stress affect testosterone?

***exam

A

causes release of glucocorticoids which can suppress testosterone levels

73
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

Medications that suppress testosterone

***exam

A
  • Suramin (Germanin)
  • Ketoconazole (Nizoral)
  • Glucocorticoids
  • Alkylating agents
  • Chronic opioids
74
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

S/S low testosterone

***exam

A
  • decreased vigor and libido
  • depression
  • fatigue
  • difficulty concentrating
  • hot flashes
  • decreased muscle mass
  • insulin resistance
  • increased body fat
  • hair loss
  • breast discomfort/gynecomastia
  • sleep disturbance
  • ED
  • decline in mental function
  • loss of bone mineral density
  • moodiness/irritability
  • metabolic syndrome
  • atherosclerosis
  • no change in deepening voice
75
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

Goal of testosterone replacement therapy

***exam

A

relieve sx and restore testosterone levels to mid-to-nl range (400 ng/dL - 600 ng/dL)

76
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

Considerations when initiating hormone replacement

***exam

A
  • Check PSA first!
  • Refer if primary hypogonadism
  • Patch, gel, cream, injection
  • evaluate q6 months
77
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

Frequency of testosterone injections

***exam

A

Q7-10 days for stable therapeutic levels

78
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

Potential risks to testosterone therapy

***exam

A
  • stimulate growth of prostate and breast ca
  • worsen sx BPH
  • liver toxicity/tumor
  • gynecomastia
  • erythrocytosis
  • testicular atrophy/infertility
  • skin dzes
  • cause/exacerbate OSA
79
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

Contraindications to testosterone tx?

***exam

A
  • liver toxicity/tumor
  • metastatic prostate ca
  • undiagnosed prostate nodule / induration
  • unexplained elevation of PSA (>3ng/mL): Jerri says may if not going up
  • erythrocytosis (hematocrit >50%)
  • Severe BPH (IPSS >19)
  • Unstable CHF (Class III or IV)
  • Untreated OSA
80
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

Testosterone monitoring: why might levels fluctuate?

***exam

A
  • circadian rhythms
  • episodic secretions
  • measurement variations
  • illness
81
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

Initial evaluation before starting testosterone tx?

***exam

A
  • CBC
  • CMP
  • TSH
  • LH
  • FSH
  • Total and Free testosterone
  • PSA (all abnormals referred to urologist who can clear for tx)
  • Prolactin
  • Estradiol
  • DRE
82
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

What to do if Testosterone <150 ng/dL on 2 morning visits

***exam

A

MRI to r/o pituitary adenoma or dz

83
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

How often to monitor testosterone tx and what tests?

***exam

A

Every 90 days

CBC, total & free testosterone, LH, FSH, estradiol, PSA

84
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

Goals to testosterone tx: life and levels

***exam

A
  • Improved QoL
  • Testosterone: 400 - 600 ng/dL
  • Free Testosterone: 15 - 20 ng/dL
85
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

Should men <40 be screened with PSA?

A

No - don’t screen <40 regardless of RFs

86
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

According to AUA guidelines, should men 40-54 be screened with PSA?

A

No - not if of average risk

If increased risk, decision should be individualized

87
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

According to AUA guidelines, should men 55-69 be screened with PSA?

A

shared decision-making. The greatest benefit of screening is with this age group.

88
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

According to AUA guidelines, for men who decide they want screening, how often should PSA screening be done?

A

an interval of every 2 years may be preferred over annual screening

89
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

According to AUA guidelines, should men 70 or over be screened with PSA?

A

Don’t screen men 70+ yo or any man with < 10 to 15 yr life expectancy. Some men age 70+ years who are in excellent health may benefit from prostate cancer screening

90
Q

Exam: screening for prostate ca in high risk groups, hypogonadism and tx w/testosterone

Should DRE be used as a screening tool for prostate cancer, according to AUA guildelines?

A

There’s no evidence to support DRE as initial screening, with or without PSA. However, DRE may be a useful secondary test in men referred to urologists for elevated PSA.

SPRING16 757 PC Adults (7 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions